Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Non-Current Assets (2016 - 2025)

Nephros (NEPH) has 16 years of Non-Current Assets data on record, last reported at $2.5 million in Q3 2025.

  • For Q3 2025, Non-Current Assets fell 16.14% year-over-year to $2.5 million; the TTM value through Sep 2025 reached $10.9 million, down 15.77%, while the annual FY2024 figure was $2.9 million, 15.74% down from the prior year.
  • Non-Current Assets reached $2.5 million in Q3 2025 per NEPH's latest filing, down from $2.7 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $4.2 million in Q3 2021 and bottomed at $2.2 million in Q3 2022.
  • Average Non-Current Assets over 5 years is $3.1 million, with a median of $3.0 million recorded in 2024.
  • Peak YoY movement for Non-Current Assets: crashed 47.2% in 2022, then grew 28.4% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $4.0 million in 2021, then tumbled by 31.82% to $2.7 million in 2022, then rose by 26.22% to $3.5 million in 2023, then dropped by 15.74% to $2.9 million in 2024, then fell by 12.74% to $2.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $2.5 million in Q3 2025, $2.7 million in Q2 2025, and $2.8 million in Q1 2025.